New drugs 99, Part IV.
Hussar
D A
DA
Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, Pa., USA.
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D000077525:Cefdinir; D002511:Cephalosporins / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D004358:Drug Therapy / Q000379:methods* / Q000451:nursing; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D000077333:Telmisartan; D013777:Tetrazoles; D014230:Triazoles / Q000627:therapeutic use; D014363:Tryptamines; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018687:Antidepressive Agents, Second-Generation; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D001713:Biphenyl Compounds; D002511:Cephalosporins; D007074:Immunoglobulin G; D007555:Isoxazoles; D018124:Receptors, Tumor Necrosis Factor; D017366:Serotonin Receptor Agonists; D013777:Tetrazoles; D014230:Triazoles; D014363:Tryptamines; D015283:Citalopram; C093622:rizatriptan; D000077525:Cefdinir; D000077339:Leflunomide; D000068800:Etanercept; C077793:candesartan cilexetil; D000077333:Telmisartan